Discontinued — last reported Q1 '18
Southern Company Allowance for Doubtful Accounts Receivable (Current) increased by 9.9% to $78.00M in Q3 2023 compared to the prior quarter. Year-over-year, this metric declined by 2.5%, from $80.00M to $78.00M. Over 2 years (FY 2020 to FY 2022), Allowance for Doubtful Accounts Receivable (Current) shows a downward trend with a -22.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | |
|---|---|---|---|---|---|---|---|---|
| Value | $88.00M | $72.00M | $78.00M | $89.00M | $94.00M | $80.00M | $71.00M | $78.00M |
| QoQ Change | — | -18.2% | +8.3% | +14.1% | +5.6% | -14.9% | -11.3% | +9.9% |
| YoY Change | — | — | — | — | +6.8% | +11.1% | -9.0% | -2.5% |